Clinical trial
Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft…
NCT00282503 · Mallinckrodt, Industry · Terminated
Key facts
| NCT number | NCT00282503 |
|---|---|
| Title | Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease |
| Official title | A Randomized, Controlled, Parallel-Group, Multicenter Study of Extracorporeal Photoimmune Therapy With THERAKOS* UVADEX* for the Treatment of Patients With Newly Diagnosed Acute Graft Versus-Host Disease |
| Lead sponsor | Mallinckrodt, Industry |
| Collaborators | PRA Health Sciences Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Graft-versus-Host Disease |
| Intervention type | Drug, Procedure |
| Interventions | Methoxsalen+ECP, Methylprednisolone, Ecp |
| Enrollment | 19 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2007 |
| First posted | Jan 26, 2006 |
| Last update posted | Aug 16, 2017 |
| Countries | Australia, Austria, Belgium, Canada, France, Germany, Italy, Netherlands, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: